Annual Closing 2024
Eurogentec will be closed from Wednesday the 25th of December 2024 until Wednesday the 1st of January 2025.
Company
New Benchmark: 1 kg of Plasmid DNA Manufactured
Kaneka Eurogentec sets new benchmark in plasmid DNA manufacturing with the production of 1 kg of plasmid DNA
GMP Compliance Verification
PSC Biotech inspection results: AnaSpec, our US subsidiary, meets the requirements to produce Active Pharmaceutical Ingredients (Drug Substance) a...
Open Day : over 300 visitors explored our facilities!
Last weekend, we had the pleasure of hosting hundreds of visitors during the Discovery Days: Chemistry and Life Sciences event, organized with Esse...
Our brand-new labs are now fully operational
After a year of revamping, we are thrilled to announce that our new Process Transfer & Development labs are ready for your projects!
We welcomed the Ambassador of Japan to Belgium at Kaneka Eurogentec
Eurogentec welcomed the Ambassador of Japan to Belgium to visit our new GMP production facilities and learn more about our COVID-19 current activit...
His Majesty King Philippe gave us the honor to visit Kaneka Eurogentec
This visit represents a great acknowledgement of our expertise in the fight against COVID-19.
Kaneka Eurogentec receives GMP accreditation for new mRNA manufacturing facility – COVID-19 vaccine production ongoing
Kaneka Eurogentec, a custom service and FDA inspected Contract Development and Manufacturing Organization (CDMO) received GMP accreditation by the ...
Kaneka Eurogentec will manufacture INOVIO’s DNA vaccine candidate against COVID-19
We will support INOVIO to produce, manufacture and scale their COVID-19 candidate, INO-4800
University of Louvain bacteria research appeals to Japan
Kaneka and its Walloon subsidiary, Kaneka Eurogentec S.A., enter into a partnership with Pr Jean-François Collet's laboratory by funding a new join...
Discovery of our facilities by Minister Willy Borsus and AWEX members
Eurogentec welcomed Minister Borsus and AWEX representatives to visit our new facilities and learn more about our COVID-19 current activity and fut...
Kaneka Eurogentec receives GMP accreditation for its new state-of-the-art facility in time for the production of DNA vaccines against COVID-19
Kaneka Eurogentec, a custom service and FDA inspected Contract Development and Manufacturing Organization (CDMO) is proud to announce the certifica...